Premier Statement on the OPPS Final Rule Last Updated: November 2, 2017
Filed under:
Print Friendly, PDF & Email

By Blair Childs, senior vice president of public affairs, Premier

Premier and its members are deeply disappointed with CMS’s decision to drastically cut by 28.5% payment to hospitals for 340B drugs used in the outpatient setting. This move is contrary to Congress’ intent in creating the 340B program and will impose major new cost pressures on safety net hospitals that care for America’s most vulnerable populations. This policy does nothing to address the rising cost of pharmaceuticals.  Instead, it threatens the ability of safety net hospitals to care for the populations they serve.

Premier is also disappointed by CMS’s decision to remove completely total knee arthroplasty (TKA) from the inpatient only list. There is a lack of clear evidence for determining appropriate settings, and this policy could harm patients.

— Blair Childs, senior vice president of public affairs, Premier

About Premier Inc.

Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 3,900 U.S. hospitals and health systems and approximately 150,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.